1/13
09:02 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $42.00.
Low
Report
Oruka Therapeutics (NASDAQ:ORKA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $42.00.
1/13
09:02 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $42.00.
Low
Report
Oruka Therapeutics (NASDAQ:ORKA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $42.00.
1/13
08:43 am
orka
Rating for ORKA
Low
Report
Rating for ORKA
1/13
08:43 am
orka
Rating for ORKA
Low
Report
Rating for ORKA
1/12
11:28 am
orka
Rating for ORKA
Medium
Report
Rating for ORKA
1/9
06:10 am
orka
Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
03:26 pm
orka
Rating for ORKA
Low
Report
Rating for ORKA
1/7
08:21 am
Oruka Therapeutics initiated with a Buy at UBS
Report
Oruka Therapeutics initiated with a Buy at UBS
1/7
02:01 am
orka
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
11/13
07:37 am
orka
Rating for ORKA
Medium
Report
Rating for ORKA
11/13
07:37 am
orka
Rating for ORKA
Medium
Report
Rating for ORKA
11/13
05:04 am
orka
Rating for ORKA
Medium
Report
Rating for ORKA
11/13
04:50 am
orka
Oruka Therapeutics initiated with a Buy at Jefferies
Medium
Report
Oruka Therapeutics initiated with a Buy at Jefferies
11/13
04:50 am
orka
Oruka Therapeutics initiated with a Buy at Jefferies
Medium
Report
Oruka Therapeutics initiated with a Buy at Jefferies
10/27
08:06 am
orka
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
10/27
08:06 am
orka
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
10/27
08:05 am
orka
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.
Medium
Report
Oruka Therapeutics (NASDAQ:ORKA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock, down previously from $45.00.
10/27
07:52 am
orka
Rating for ORKA
Low
Report
Rating for ORKA
10/27
07:52 am
orka
Rating for ORKA
Low
Report
Rating for ORKA
10/27
06:26 am
orka
Oruka Therapeutics initiated with a Buy at Guggenheim
Low
Report
Oruka Therapeutics initiated with a Buy at Guggenheim
10/27
06:26 am
orka
Oruka Therapeutics initiated with a Buy at Guggenheim
Low
Report
Oruka Therapeutics initiated with a Buy at Guggenheim